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5. Claim your CME credit and receive your certificate electronically by following the instructions given at the conclusion of the activity. CME Objective for This Article: After reading this article the reader should be able to: 1) recognize the importance of arrhythmic risk assessment even in early ARVC disease to enable adequate treatment and follow up;
2) understand how to integrate information from multiple examination modalities to obtain optimal information on arrhythmic risk; and 3) describe electrical and echocardiographic alterations in ARVC patients, focusing on early changes to enable early detection of disease and increased arrhythmic risk.
A rrhythmogenic right ventricular cardiomyopathy (ARVC) is an inheritable cardiomyopathy that predisposes to life-threatening arrhythmias and heart failure, and is one of the leading causes of sudden cardiac death (SCD) in young individuals (1) . Ventricular arrhythmias are frequent in patients with ARVC and, importantly, arrhythmias may occur also in early stages of disease, making risk stratification challenging (2) . Furthermore, the patients with ARVC seen in cardiological clinics have changed over the past decade. Fifteen years ago, patients were typically diagnosed with overt ARVC after they had survived a life-threatening arrhythmic event. Genetic family screening now identifies individuals at risk of developing ARVC before onset of symptoms of disease. Hence risk stratification has moved from assessing obvious myocardial pathology to predicting the transition from asymptomatic, mutation positive ARVC to electrical disease with potential life-threatening ventricular arrhythmias (3) . Of importance, outcome is favorable in patients detected early and treated according to guidelines (4) . Tools are needed to detect early disease and to optimize medication and timing of implantation of a cardioverter defibrillator (ICD) to prevent SCD becoming the first symptom of ARVC.
The Task Force Criteria revised in 2010 (TFC 2010) improved sensitivity and specificity of ARVC diagnosis (5) . Newer echocardiographic techniques, such as strain echocardiography, have shown promising results in ARVC risk stratification in previous studies (6, 7) . We aimed to explore early markers of ARVC disease and their association with previous ventricular arrhythmias. We hypothesized that a combination of electrocardiographic parameters and imaging parameters, including strain echocardiography, may
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improve risk stratification of arrhythmic events in subjects with ARVC. ECHOCARDIOGRAPHIC STUDIES. Two-dimensional echocardiographic studies were performed on a Vivid 7 or 9 (GE Healthcare, Horten, Norway) and data were analyzed with EchoPAC version 112 (GE Healthcare).
METHODS
Data analyses were performed blinded to patient clinical data. GENETIC ANALYSES. Genetic testing was performed as previously described (12) Leren et al.
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TOTAL ARVC POPULATION. In the total ARVC population, RV and RVOT diameters were markers of arrhythmic events (both p < 0.001) ( Table 2) . RV function by RV FAC and RV global longitudinal strain were decreased in subjects with arrhythmic events (both p < 0.01) ( Table 2) Table 2) , also when adjusted for beta-blocker use, age, sex, and mutation status in multivariable analyses (all p # 0.05).
QRS duration did not differ between ARVC with and without arrhythmic events, whereas T-wave inversions were more prevalent in subjects with arrhythmic events (p < 0.001) ( Table 2 ). All 3 parameters from signal-averaged ECGs were markers of arrhythmic events (all p < 0.001) ( Table 2) . Values are mean AE SD, n (%), or n.
AVRC ¼ arrhythmogenic right ventricular cardiomyopathy; BMI ¼ body mass index. ARVC ¼ arrhythmogenic right ventricular cardiomyopathy; ECG ¼ electrocardiogram. (Figure 3 ).
There were no significant differences in QRS duration or presence of T-wave inversions (p ¼ 0.27) between subjects with and without arrhythmic events (Table 3) . Only 1 subject had S-wave upstroke >55 ms (Table 3) .
EARLY ARVC ARRHYTHMIC RISK ASSESSMENT. To assess arrhythmic risk in subjects with early ARVC, we evaluated the presence of major and minor elec- FEASIBILITY AND VARIABILITY ANALYSES. LV and RV strain analyses could be performed in 89% and has previously been shown to be a marker of arrhythmias in ARVC and other cardiac diseases (7, (12) (13) (14) (15) . In ARVC, structural changes, and fibrosis in particular, are likely substrates for the increased mechanical dispersion. RV mechanical dispersion in ARVC detects segments with subtle dyskinesia in early disease and may reflect the start of fibrosis and arrhythmic risk. We have previously shown that asymptomatic ARVC mutation-positive family members also had more pronounced RV mechanical dispersion than healthy controls, indicating a continuum of risk (7). The current study included a large cohort and focused on arrhythmias in early disease and showed the additive effect of imaging to electrical parameters in detecting high risk individuals.
LV STRUCTURAL AND FUNCTIONAL CHANGES. LV affection in ARVC is now commonly recognized (16).
In the total ARVC population, parameters of LV function and timing, including LVEF, were markers of previous arrhythmic events. These findings support that overt ARVC disease commonly include the Values are n (%) or mean AE SD. The p value by independent Student t test or chi-square test.
RBBB ¼ right bundle branch block; other abbreviations as in Table 2 . In a recent paper, time from onset of QRS to start of regional shortening in the sub-tricuspid area was a marker of ventricular arrhythmias in asymptomatic ARVC mutation carriers (25) , emphasizing the role of echocardiography in risk stratification. Alterations in s 0 have also been described in ARVC, including early ARVC (26, 27) .
In our population, only 1 subject with early ARVC had an S-wave upstroke >55 ms, which has previously been described as a common and early finding in ARVC (9, 25) and a predictor of arrhythmic events (25) .
This discrepancy may be explained by the different definitions of S-wave upstroke (9, 25) .
CLINICAL IMPLICATIONS. ARVC mutation-positive family members with no apparent or only early disease constitute a substantial proportion of current ARVC populations seen in cardiomyopathy clinics.
Risk stratification of SCD in these individuals has not ACKNOWLEDGMENTS The authors thank all of the study participants. Chi-square statistics were used a measure of the ability to detect arrhythmic events and showed that the model for identifying subjects with arrhythmic events was improved both in early ARVC (A) (chi-square increased from 4.7 to 10.0; p ¼ 0.05) and in the total ARVC population (B)
(chi-square increased from 28.1 to 48.1; p < 0.001) when adding measurements of RV diameter and RV mechanical dispersion to the presence of electrical abnormalities alone. RVMD ¼ right ventricular mechanical dispersion; other abbreviations as in Figures 1 and 2 . 
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